Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
about
Norovirus immunity and the great escapeImmunogenetic mechanisms driving norovirus GII.4 antigenic variationAntiviral targets of human norovirusesMolecular epidemiology of norovirus in Singapore, 2004-2011.Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunityComparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.Evolutionary Constraints on the Norovirus Pandemic Variant GII.4_2006b over the Five-Year Persistence in Japan.Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Vaccine against norovirus.The state of norovirus vaccines.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.The dynamics of GII.4 Norovirus in Ho Chi Minh City, VietnamChimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Within-host evolution results in antigenically distinct GII.4 norovirusesParticle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid.Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trialLlama nanoantibodies with therapeutic potential against human norovirus diarrhea.Contribution of intra- and interhost dynamics to norovirus evolution.Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein.Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigensPreclinical dose-ranging studies of a novel dry powder norovirus vaccine formulationThe importance of intergenic recombination in norovirus GII.3 evolutionPattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particlesNorovirus vaccines: Correlates of protection, challenges and limitationsStructural basis for norovirus neutralization by an HBGA blocking human IgA antibodyIdentification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.Histo-blood group antigens: a common niche for norovirus and rotavirus.Human Norovirus Evolution in a Chronically Infected Host.Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides.Methods for ascertaining norovirus disease burdens.Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China.Seroprevalence in Household Raised Pigs Indicate High Exposure to GII Noroviruses in Rural Nicaragua.Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.Structural Constraints on Human Norovirus Binding to Histo-Blood Group AntigensAssessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.Seroprevalence of antibodies against GII.4 norovirus among children in Pune, India.
P2860
Q21090486-346906FF-926F-45E7-BDCC-DEA7F7B2B848Q24810360-8A100822-7626-4BA9-A7EF-66C5A44A606AQ30249527-EDCC86CF-29F3-42A8-AA7B-70FF17F1CC47Q30352203-D8955A66-1F43-4B96-941F-24065AB3B210Q30352529-6A48322B-9BCE-454D-A8F3-572D077B8532Q30383126-EA3D1E26-13DB-43B9-89F5-C385710BFBD0Q30400409-B8A8A1F4-1774-424E-9FE1-3247F03D2EC5Q30401642-B57B65EB-EDB5-42CC-AFC9-726E278E3771Q30425145-526E1E52-F8ED-4B45-889F-DFA732E74981Q33578075-3AF8E07F-FF3B-4E37-B09A-A4DAA35A56ABQ33678125-F9547AB3-0C4D-4963-B4EB-AF1C5E1D3B10Q33703664-5120A5E3-AA73-4C17-8485-81961084C6F4Q33719999-DA54F32E-5B87-4A67-A3B4-311FE66D091FQ33743992-68E30BEE-9523-4389-B362-B13FDEA94625Q33744124-5FA521A7-7315-4D73-BCF7-C5A662CA4A4DQ34059136-428E67F6-8654-4EF5-A30C-C29547850053Q34785721-D915B206-12F8-4621-9B87-D9772210AB19Q35212408-45447715-0490-40EC-833A-198FCE35AFBEQ35744232-AA2C30A4-24F1-472A-B1D7-655A62A690BAQ35826200-D3582AD7-02A4-4109-AA4E-3EDEE6E875EDQ36052875-5284FDE0-3764-414B-8E71-9AE2B703AB81Q36155501-2B1C6CCD-3CF6-45A6-B176-10E5428E1E87Q36642590-063B2288-7931-4590-8601-B89B31CAB269Q36759705-DA9374A3-E66F-46D1-A952-A1AADD1C0E64Q36898311-F17CA9A0-8B83-418C-806B-0C38419BE50EQ37135476-8BCA8542-55CB-4B68-A1AE-42A58E6A36B0Q37323139-001AAA48-C718-409F-8E17-744AE27445D8Q37547097-2D62A75E-1A5E-489F-A5A7-E71C9114DCB5Q37547547-5090154A-F3D0-48B1-B4D3-3AD1DF27F2AEQ38194256-E8389420-BE71-459E-83F9-70F76FB407F9Q38288362-7C969898-25C2-41AD-8BFB-677832BB0672Q38293732-D0A03B5D-D009-4D3C-8B40-798B99748C25Q38869777-6C2AA4FE-71DB-4675-8306-547A97E6EBCBQ39471943-FED2D26F-9D74-4A9B-8C1D-EF8461516918Q39770349-08DFBB31-4A9D-4C7A-B237-00BB85C065D1Q40044140-1FB11E32-857B-420E-9B38-E48F251AD18CQ40243520-354B6F2E-429A-464C-B213-CBB717A28BF2Q40700480-F1EDB404-54B2-4985-B1FD-2BA904741B8DQ40715789-FDE454BC-B909-4052-93E9-16069624FC3BQ40794900-C1D0E9BC-701C-4E61-AB74-8CAB704B3183
P2860
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@ast
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@en
type
label
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@ast
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@en
prefLabel
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@ast
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@en
P2093
P2860
P50
P356
P1433
P1476
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
@en
P2093
Eric F Donaldson
Jesica Swanstrom
Lisa C Lindesmith
P2860
P304
P356
10.1128/JVI.06200-11
P577
2011-11-16T00:00:00Z